• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮样支气管源性癌的术前化疗

Preoperative chemotherapy in epidermoid bronchogenic carcinoma.

作者信息

Morere J F, Israel L, Breau J L, Clavier J, Guillerm D, Zabbe C, Raut Y, Morere P, Nouvet G, Lerebours Pigeonniere G

出版信息

Drugs Exp Clin Res. 1985;11(3):233-5.

PMID:2424702
Abstract

Palliative chemotherapy in cases of epidermoid bronchogenic carcinoma, initially judged to be inoperable, made it possible to perform operative resection in 50 cases. An association of cis-platinum and bleomycin was used, this combination having previously been considered synergistic. In certain cases the tumour seemed to have disappeared on macroscopic examination of the resected specimen, and in some instances no tumoral cells could be found on histological examination. This series brought out several positive features: chemotherapy made it possible to operate on patients previously judged to be inoperable; it ensured maximum local efficiency of drugs because of the absence of abnormal vascularity; and it made it possible to anticipate the cure of occult metastases. However, three negative aspects were also present: modification of postoperative TNM classification making it difficult to establish a prognosis; difficulty in determining therapeutic strategy for pNo; and inadequate long-term follow-up. On the whole the positive points appeared to outweigh the negative aspects, but a randomized study is necessary to confirm this.

摘要

对于最初判定为无法手术的表皮样支气管癌病例,姑息化疗使50例患者能够进行手术切除。采用了顺铂和博来霉素联合用药,此前认为这种联合具有协同作用。在某些病例中,切除标本的宏观检查显示肿瘤似乎已消失,在一些情况下,组织学检查未发现肿瘤细胞。该系列研究呈现出几个积极特征:化疗使先前判定为无法手术的患者能够接受手术;由于不存在异常血管,确保了药物的最大局部疗效;并且能够预见隐匿性转移灶的治愈情况。然而,也存在三个消极方面:术后TNM分类的改变使得难以建立预后;确定pNo的治疗策略存在困难;以及长期随访不足。总体而言,积极方面似乎超过消极方面,但需要进行随机研究来证实这一点。

相似文献

1
Preoperative chemotherapy in epidermoid bronchogenic carcinoma.表皮样支气管源性癌的术前化疗
Drugs Exp Clin Res. 1985;11(3):233-5.
2
Surgery and chemotherapy. A new method of treatment for squamous cell bronchial carcinoma.手术与化疗。一种治疗鳞状细胞支气管癌的新方法。
J Thorac Cardiovasc Surg. 1984 Nov;88(5 Pt 1):754-7.
3
Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
Cancer Treat Rep. 1980 Apr-May;64(4-5):717-9.
4
Effects of long-term adjuvant chemotherapy with cyclophosphamide (NSC-26271) for radically resected bronchogenic carcinoma.
Cancer Chemother Rep 3. 1973 Mar;4(2):125-32.
5
[Association of methylprednisolone in the bleomycin treatment of patients with bronchogenic carcinoma].[甲基强的松龙在博来霉素治疗支气管源性癌患者中的联合应用]
G Ital Chemioter. 1978 Jan-Jun;25(1):53-5.
6
[Drug therapy in bronchial carcinoma].[支气管癌的药物治疗]
Schweiz Med Wochenschr. 1995 Jul 22;125(29):1396-405.
7
[Preliminary results concerning the value of chemotherapy in the treatment of inoperable bronchial carcinoma (excluding small-cell anaplastic carcinoma)].[关于化疗在无法手术的支气管癌(不包括小细胞间变性癌)治疗中的价值的初步结果]
Rev Pneumol Clin. 1984;40(2):127-9.
8
[Long-term survival after pulmonary resection in bronchogenic carcinoma (author's transl)].支气管源性癌肺切除术后的长期生存(作者译)
Wien Klin Wochenschr. 1981 May 15;93(10):325-8.
9
[Combination of cisplatin-mitomycin-vindesine for inoperable, non-small-cell bronchial cancers. French study group in pneumo-cancerology].
Rev Mal Respir. 1993;10(4):307-12.
10
Combination of surgery and polychemotherapy for cure in early small-cell bronchial carcinoma.手术联合多药化疗治愈早期小细胞支气管癌。
Bull Cancer. 1982;69(1):94-7.